543 related articles for article (PubMed ID: 15872368)
41. Chromosome damage in thyroid cells of adults irradiated with x-rays in infancy.
Doida Y; Hoke C; Hempelmann LH
Radiat Res; 1971 Mar; 45(3):645-56. PubMed ID: 5574234
[No Abstract] [Full Text] [Related]
42. Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131.
M'Kacher R; Schlumberger M; Légal JD; Violot D; Béron-Gaillard N; Gaussen A; Parmentier C
J Nucl Med; 1998 May; 39(5):825-9. PubMed ID: 9591584
[TBL] [Abstract][Full Text] [Related]
43. Why should the radioiodine dose be different in patients with differentiated thyroid carcinoma prepared with recombinant human TSH?
Pitoia F; Degrossi OJ; Niepomniszcze H
Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):924; author reply 924-5. PubMed ID: 15034676
[No Abstract] [Full Text] [Related]
44. Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma.
Salvatori M; Luster M
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):821-8. PubMed ID: 20186542
[No Abstract] [Full Text] [Related]
45. Side effects of "rational dose" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma.
Van Nostrand D; Neutze J; Atkins F
J Nucl Med; 1986 Oct; 27(10):1519-27. PubMed ID: 3760975
[TBL] [Abstract][Full Text] [Related]
46. [Clinical picture and possible causes of functional disorders of the parotid gland in radioiodine therapy of differentiated thyroid cancer].
Deeg M; Maier H; Bihl H; Adler D
Laryngol Rhinol Otol (Stuttg); 1988 Jul; 67(7):362-6. PubMed ID: 3210869
[TBL] [Abstract][Full Text] [Related]
47. Radiation Dose-rate Reduction Pattern in Well-differentiated Thyroid Cancer Treated with I-131.
Khan SA; Khan MS; Arif M; Durr-e-Sabih ; Rahim MK; Ahmad I
J Coll Physicians Surg Pak; 2015 Jul; 25(7):510-3. PubMed ID: 26208555
[TBL] [Abstract][Full Text] [Related]
48. Thyroid stunning in vivo and in vitro.
Medvedec M
Nucl Med Commun; 2005 Aug; 26(8):731-5. PubMed ID: 16000993
[TBL] [Abstract][Full Text] [Related]
49. [Myelodysplastic syndrome following radioiodine treatment of differentiated carcinoma of the thyroid].
García Pascual L; Simó R; Mesa J; Galofré P
Rev Clin Esp; 1992 Jul; 191(3):169-70. PubMed ID: 1502411
[No Abstract] [Full Text] [Related]
50. Radiation effects of radiodine on the thyroid. Effects vary with dosage and sensitivity of the gland to radiation.
Dobyns BM
R I Med J (1974); 1975 Mar; 58(3):94-7, 122-5. PubMed ID: 124920
[No Abstract] [Full Text] [Related]
51. Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma.
M'Kacher R; Légal JD; Schlumberger M; Aubert B; Beron-Gaillard N; Gaussen A; Parmentier C
J Nucl Med; 1997 Mar; 38(3):377-80. PubMed ID: 9074522
[TBL] [Abstract][Full Text] [Related]
52. Radioactive iodine in thyroid medicine--how it started in Sweden and some of today's challenges.
Mattsson S; Johansson L; Jönsson H; Nosslin B
Acta Oncol; 2006; 45(8):1031-6. PubMed ID: 17118834
[TBL] [Abstract][Full Text] [Related]
53. Epiphora after radioactive iodine therapy in a low-risk patient.
Song H; Jeong J; Ju Koh M
Clin Nucl Med; 2015 Jun; 40(6):536-7. PubMed ID: 25674875
[TBL] [Abstract][Full Text] [Related]
54. Dosimetry and thyroid cancer: the individual dosage of radioiodine.
Lassmann M; Reiners C; Luster M
Endocr Relat Cancer; 2010 Sep; 17(3):R161-72. PubMed ID: 20448022
[TBL] [Abstract][Full Text] [Related]
55. Cytogenetic effects of radioiodine therapy: a 20-year follow-up study.
Livingston GK; Khvostunov IK; Gregoire E; Barquinero JF; Shi L; Tashiro S
Radiat Environ Biophys; 2016 May; 55(2):203-13. PubMed ID: 27015828
[TBL] [Abstract][Full Text] [Related]
56. [Environmental radiation exposure of a thyroid cancer patient resulting from adjuvant iodine radiotherapy].
Chaś J; Kowalczyk A; Siekierzyński M; Dziuk E; Janiak MK
Wiad Lek; 2001; 54 Suppl 1():312-20. PubMed ID: 12182042
[TBL] [Abstract][Full Text] [Related]
57. Chromosome aberrations after high-dose 131I and 99mTc-MIBI administration using a micronucleus assay.
Asli IN; Mosaffa N; Mogharrabi M; Hooman A; Tabei F; Javadi H; Shafei B; Seyedabadi M; Assadi M
Nucl Med Commun; 2010 Apr; 31(4):307-10. PubMed ID: 20072074
[TBL] [Abstract][Full Text] [Related]
58. [Effective focal doses and the radiation loads in the radioiodine therapy of thyroid cancer].
Ivanitskaia VI; Shantyr' VI; Pudovkina LF; Kozhukhov VD
Med Radiol (Mosk); 1981 Nov; 26(11):6-12. PubMed ID: 7332697
[No Abstract] [Full Text] [Related]
59. DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy.
Eberlein U; Scherthan H; Bluemel C; Peper M; Lapa C; Buck AK; Port M; Lassmann M
J Nucl Med; 2016 Feb; 57(2):173-9. PubMed ID: 26564321
[TBL] [Abstract][Full Text] [Related]
60. Biological dosimetry and Bayesian analysis of chromosomal damage in thyroid cancer patients.
Serna A; Alcaraz M; Navarro JL; Acevedo C; Vicente V; Canteras M
Radiat Prot Dosimetry; 2008; 129(4):372-80. PubMed ID: 17951242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
